George E. Reier
FMC Corporation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by George E. Reier.
Pharmaceutical Development and Technology | 2001
Shilpa S. Thosar; Reba A. Forbess; Nkere K. Ebube; Yixin Chen; Ronald L. Rubinovitz; Mark S. Kemper; George E. Reier; Thomas A. Wheatley; Atul J. Shukla
Drug contents of intact tablets were determined using non-destructive near infrared (NIR) reflectance and transmittance spectroscopic techniques. Tablets were compressed from blends of Avicel® PH–101 and 0.5% w/w magnesium stearate with varying concentrations of anhydrous theophylline (0, 1, 2, 5, 10, 20 and 40% w/w). Ten tablets from each drug content batch were randomly selected for spectral analysis. Both reflectance and transmittance NIR spectra were obtained from these intact tablets. Actual drug contents of the tablets were then ascertained using a UV-spectrophotometer at 268 nm. Multiple linear regression (MLR) models at 1116 nm and partial least squares (PLS) calibration models were generated from the second derivative spectral data of the tablets in order to predict drug contents of intact tablets. Both the reflectance and the transmittance techniques were able to predict the drug contents inintact tablets over a wide range. However, a comparison ofthe results of the study indicated that the lowest percent errors of prediction were provided by the PLS calibration models generated from spectral data obtained using the transmittance technique.
Pharmaceutical Development and Technology | 1999
N. K. Ebube; Shilpa S. Thosar; R. A. Roberts; Mark S. Kemper; Ronald L. Rubinovitz; D. L. Martin; George E. Reier; Thomas A. Wheatley; Atul J. Shukla
The purpose of this study was to use near-infrared spectroscopy (NIRS) as a nondestructive technique to (a) differentiate three Avicel products (microcrystalline cellulose [MCC] PH-101, PH-102, and PH-200) in powdered form and in compressed tablets with and without 0.5% w/w magnesium stearate as a lubricant; (b) determine the magnesium stearate concentrations in the tablets; and (c) measure hardness of tablets compressed at several compression forces. Diffuse reflectance NIR spectra from Avicel powders and tablets (compression forces ranging from 0.2 to 1.2 tons) were collected and distance scores calculated from the second-derivative spectra were used to distinguish the different Avicel products. A multiple linear regression model was generated to determine magnesium stearate concentrations (from 0.25 to 2% w/w), and partial least squares (PLS) models were generated to predict hardness of tablets. The NIRS technique could distinguish between the three different Avicel products, irrespective of lubricant concentration, in both the powdered form and in the compressed tablets because of the differences in the particle size of the Avicel products. The percent error for predicting the lubricant concentration of tablets ranged from 0.2 to 10% w/w. The maximum percent error of prediction of hardness of tablets compressed at the various compression forces was 8.8% for MCC PH-101, 5.3% for MCC PH-102, and 4.6% for MCC PH-200. The NIRS nondestructive technique can be used to predict the Avicel type in both powdered and tablet forms as well as to predict the lubricant concentration and hardness.
Archive | 1998
Michael Augello; Sheila M. Dell; George A. Agyilirah; George E. Reier
Archive | 1999
Michael Augello; Sheila M. Dell; George E. Reier; Howard J. Stamato; Lynn M. Dimemmo
Archive | 1996
Michael Auguello; Thomas Ruszkay; George E. Reier
Pharmaceutical Development and Technology | 1996
Yacoub S. Habib; Larry L. Augsburger; George E. Reier; Thomas A. Wheatley; Ralph F. Shangraw
Archive | 1998
Michael Augello; George E. Reier
Archive | 1997
Michael Auguello; Thomas Ruszkay; George E. Reier
Archive | 1999
Michael Augello; Sheila M. Dell; George E. Reier; Howard J. Stamato; Lynn M. Dimemmo
Archive | 1999
Michael Augello; Sheila M. Dell; Lynn M. Dimemmo; George E. Reier; Howard J. Stamato